Skip to main content
. 2022 Oct 19;16(3):162–169. doi: 10.1177/1753495X221133150

Table 3.

Comparison of pregnancy studies in CKD.

Wu et al. 3 Chapman et al. 5 Piccoli et al. 4 Wiles ADTKD Cohort Study
Population ADPKD ADPKD CKD Stage 2 CKD Stage 3 3a 3b Unaffected Estimated CKD Stage 1 Estimated CKD Stage 2 Estimated CKD Stage 3 Estimated CKD Stage 4
Mothers (n) 54 235 23 35 women with ADTKD-MUC1 and 50 with ADTKD-UMOD
Pregnancies (n) 92 485 87 37 79 38 50 32 58 54 15
BMI (kg/m2 mean  ±  SD) 26.4 24.9 23.0  ±  4.5 22.21  ±  3.30 23.58  ±  5.35 21.59  ±  2.18 22.96  ±  4.99
Mean age (years; mean  ±  SD) 29  ±  6.2 33.8  ±  4.5 33.5  ±  4.1 33.2 33.1 29.3  ±  4.1 27.41  ±  5.02 28.69  ±  4.79 26.40  ±  4.78 27.14  ±  4.52
Hypertension prior to pregnancy (n or % as given in paper) ≥20% 16% 41% 54% 71% 87% 0 1 (3%) 3 (5%) 6 (11%) 2 (13%)
Hypertension during pregnancy (baseline HTN  +  new onset HTN) ≥32% 32% 52% 76% ≥71% ≥87% 6 (12%) 5 (16%) 9 (16%) 17 (31%) 4 (27%)
New onset hypertension (n) 12% 16% 18% 47% 6 (12%) 4 (13%) 6 (11%) 11 (23%) 2 (17%)
Edema (n) 11% 25% 12 (24%) 2 (6%) 20 (34%) 16 (30%) 7 (47%)
Preeclampsia (n) 9% 11%
Premature delivery (<37 weeks) (n or % as given in paper) 11% 9% 51% 78% 41% 62% 0 1 (3%) 2 (3%) 12 (21%) 1 (7%)
Cesarean section (n or % as given in paper) 14% 7% 70% 78% 51% 65% 19 (38%) 6 (19%) 8 (14%) 13 (24%) 4 (27%)
NICU stay 28 44 24% 41% 3 (6%) 2 (6%) 5 (9%) 11 (20%) 1 (7%)
Birth weight (g) (mean  ±  SD) 3289  ±  746 2484  ±  707 2226  ±  582 2750 2490 3760  ±  581 3352  ±  621 3515  ±  540 2993  ±  721 3293  ±  744
Decline in eGFR (ml/min/1.73 m2/year) 2.9 4.6